Multiple endocrine neoplasia syndrome type 1 (MEN1), which is secondary to mutation of
the MEN1 gene, is a rare autosomal-dominant disease that predisposes mutation carriers to …

Pheochromocytomas and paragangliomas are neuroendocrine tumors that occur in the context
of inherited cancer syndromes in ∼30% of cases and are linked to germline mutations in …

Cardio-facio-cutaneous (CFC) syndrome, Noonan syndrome (NS), and Costello syndrome (CS)
are clinically related developmental disorders that have been recently linked to …

In 5‐10% of patients, neurofibromatosis type 1 (NF1) results from microdeletions that
encompass the entire NF1 gene and a variable number of flanking genes. Two recurrent …

Succinate dehydrogenase (SDH) deficiency represents a minor cause of Leigh syndrome (LS).
Noticeably, the first mutation in a nuclear-encoded respiratory chain component, a …

Neurofibromatosis type 1 ( NF 1) affects about one in 3,500 people in all ethnic groups. Most
NF 1 patients have private loss‐of‐function mutations scattered along the NF 1 gene. Here, …

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder which displays
considerable inter- and intra-familial variability in phenotypic expression. To evaluate the …

Germline mutations in the RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, MAX, TMEM127,
NF1 or VHL genes are identified in about 30% of patients with pheochromocytoma or …

Context: Half of the patients with Noonan syndrome (NS) carry mutation of the PTPN11 gene,
which plays a role in many hormonal signaling pathways. The mechanism of stunted …

The recent cloning of a second estrogen receptor (ER), designated ERβ, has prompted a
reevaluation of the role of ERs in breast cancer. We have developed and validated a real-time …